Advanced Hepatocellular Carcinoma in A Scottish Population – Current Experience and the Future
Journal Title: Current Trends in Gastroenterology and Hepatology - Year 2018, Vol 1, Issue 3
Abstract
Sorafenib is the current first line standard of care in patients with advanced hepatocellular carcinoma (HCC). Several other drugs are emerging as efficacious agents in this setting. This article will outline our current real-world experience with sorafenib in a Scottish population as well as discuss the evidence behind new potential therapies. Hepatocellular carcinoma (HCC) is the fifth most common cancer affecting patients worldwide and accounts for 2% of cancer cases in the United Kingdom [1,2]. Incidence is rising and it is associated with several known risk factors including heavy alcohol consumption, non-alcoholic steatohepatitis and chronic hepatitis B and C infection [3,4]. If detected at an early stage, HCC is potentially curable. Unfortunately, many patients are diagnosed at an advanced stage (according to the Barcelona Clinic Liver Cancer criteria) and treatment is therefore palliative focusing on prolonging survival and improving symptom burden. In the advanced setting, sorafenib is recommended as first line option in patients who cannot benefit from resection, transplantation, ablation or transarterial chemoembolization (TACE), and who still have preserved liver function [5]. Sorafenib is the only drug that has shown a significant survival benefit in the last decade. It is a multi-kinase inhibitor with particular action against VEGFR2, PDGFR, FGFR1, Raf-1, B-Raf and c-Kit receptors [6].
Authors and Affiliations
Baxter MA, Peters AL, Graham J
Assessment of the Depression‐level effectiveness of the Curse Words in Young Adults in Private Co-Educational Pharmaceutical Instituions in Pune University, India: A Preplanned, Causal‐Pathway‐Based Analysis
Depression and substance abuse is on the increase all over the world. The poor and the rich are also involved in this dangerous habit has impact not only on reproductive health but also has impact on family, society, inc...
Eradication Failure of Helicobacter Pylori Among Children’s Population
Helicobacter pylori (H. pylori) is a Gram-negative bacterium responsible for the development of gastritis that may further progress to more severe conditions, peptic ulcer disease and gastric cancer [1,2]. H. pylori have...
Utilization of Traditional Anticoagulation for Venous Thromboembolism in Patients with Liver Cirrhosis: Is It Safe?
Patients with liver cirrhosis are known to have increased risk bleeding particularly from gastrointestinal tract. However, recent literature has shown that patients with liver cirrhosis are also at increased risk of deve...
Non-Surgical Pneumoperitoneum Complicating Mechanical Ventilation
The occurrence of a pneumoperitoneum is usually linked to intra-abdominal hollow-organ perforation and generally requires emergency abdominal surgery. In 5 to 15% of cases, the pneumoperitoneum is not related to organ pe...
Hygiene and Dietary Measures in the Treatment of Type 2 Diabetes Population of Chief Region (Algeria)
Diabetes mellitus is a chronic, sometimes silent disease that exposes cardio-vascular morbidities by its micro and macroangiopathic complications with heavy socio-economic repercussions. Strategies of various kinds are p...